Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 123 results found. Search for [ COVID-19 vaccine Gamaleya ]

Results 40 to 60 of 123
PTI
December 16, 2020
The applications are being examined on scientific basis, using the frameworks that are scientific, frameworks that are globally aligned and ensuring that the vaccine is safe, NITI Aayog member (health) Dr V K Paul said


Rashi Bisaria
New Delhi, December 15, 2020
Gmail, YouTube, other Google services back after massive global outage Google services including YouTube and Gmail are back after an outage that lasted close to an hour. Users worldwide are now reporting that the services of the tech giant have resumed functionality. YouTube was apparently the last service to have had its glitch rectified, while services like Gmail were reportedly brought back to normalcy faster. COVID-19 vaccine: Russia's Sputnik V shows 91.4% efficacyRussia's Sputnik V...


BusinessToday.In
December 14, 2020
Calculation was based on the analysis of data of volunteers who received both the first and second doses of the Sputnik V vaccine or placebo at the third and final control point of 78 confirmed cases in accordance with the Phase III clinical trials protocol


BusinessToday.In
December 11, 2020
AstraZeneca's vaccine has an average efficacy of 70.4 per cent, according to data published in a journal. Russia, meanwhile, has said that Sputnik V is 92 per cent effective


PB Jayakumar
December 11, 2020
Sputnik V in India: India's Dr Reddy's Laboratories and Hetero Drugs have a license to sell 100 million doses of the vaccine in India and limited trials are also being done in the country, as part of the approval process


PTI
December 8, 2020
Over the last four days, the Indian arm of US pharmaceutical giant Pfizer, Pune-based Serum Institute of India and Hyderabad-based pharmaceutical firm Bharat Biotech have applied to the Drugs Controller General of India (DCGI) seeking emergency use authorisation


BusinessToday.In
December 8, 2020
Coronavirus vaccine update: The ministry also said that India has eight coronavirus vaccine candidates in the making. Out of the eight, two have applied for emergency use authorisation


BusinessToday.In
December 2, 2020
The decision comes as Russia recorded 589 new deaths on a day; Russian Deputy Prime Minister Tatiana Golikova that large-scale vaccinations on voluntary basis will began across the country soon


BusinessToday.In
December 1, 2020
Dr. Reddy's and RDIF had partnered up in September 2020, so as to conduct clinical trials of the Sputnik V vaccine, as well as having the rights for distribution of its first 100 million doses in India.


BusinessToday.In
November 30, 2020
As number of patients has doubled from 95 to 196, Moderna has reported a drop in efficacy for its COVID-19 vaccine from 94.5 per cent to 94.1 per cent


BusinessToday.In
November 30, 2020
There are only five companies that have given preliminary data about how effective their vaccines could be to fight against coronavirus. These five companies include Pfizer-BioTech, Moderna Inc, Oxford University-AstraZeneca Plc, and Gamaleya Institute


PB Jayakumar
November 28, 2020
Prime Minister Narendra Modi's visit to these facilities and discussions with the scientists are to help him get a first-hand perspective of the preparations, challenges and roadmap in India's vaccination plans


PB Jayakumar
November 27, 2020
The vaccine supplies for the global market will be produced by RDIF's international partners in India, Brazil, China, South Korea and other countries. The safety of vaccines based on human adenoviruses has been confirmed in more than 75 international publications and in more than 250 clinical trials.


Manoj Sharma
November 27, 2020
New vaccines are rarely certified for efficacy above 90 per cent. Their efficacy improves as millions are vaccinated over decades. In fact, most vaccines get certified in the 40-60 per cent efficacy band


BusinessToday.In
November 27, 2020
The Russian Gamaleya research institute, the creator of Sputnik V vaccine for COVID-19, has suggested to UK pharmaceutical company AstraZeneca to try to boost the efficacy of its COVID-19 vaccine, combining it with a shot of its own vaccine.


Rajeev Dubey
New Delhi, November 25, 2020
In stark contrast to the mayhem around the world, India's top three candidates - Serum-Oxford, Bharat Biotech and Zydus Cadila continued their scientific pursuits unobtrusively (the fourth, DRL-Gamaleya, just started India trials). At least 16 more vaccines are under development at home


Vivek Punj
New Delhi, November 25, 2020
Ali Express, AliPay, CamCard among 43 Chinese apps banned India on Tuesday banned 43 Chinese mobile apps, under Section 69A of the Information Technology Act. The government said the apps engaged in activities \"prejudicial to India's sovereignty, integrity, defence, security, and public order.\" The list of banned apps include AliExpress, AliSuppliers, Lalamove India, Mango TV amongst others.Russia's Sputnik V shows 90% efficacy against COVID-19; to be priced under $20Russia has claimed...


Joe C Mathew
November 24, 2020
The announcement that comes a day after Oxford-Astrazeneca announced a similar level of efficacy for its COVID-19 vaccine allows India to hope for two vaccines to fight the COVID-19 pandemic in the country


BusinessToday.In
November 24, 2020
Russia's Sputnik V coronavirus vaccine has shown 95% efficacy, according to a second interim analysis of its human clinical trial data


Rajeev Dubey
November 20, 2020
Emboldened, firms indulge in a game of one-upmanship based on alarmingly low number of trials. Sputnik had been tried on only 20 patients before Gamaleya made the claim; Pfizer 120 and Moderna 95


PAGES 3 OF 7  12345